1,663
Views
96
CrossRef citations to date
0
Altmetric
Original Articles

α-Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes

&

References

  • Adult Treatment Panel II. (1994). National Cholesterol Education Program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Circulation. 89:1333–1345.
  • Akihisa, T., Yasukawa, K., Yamaura, M., Ukiya, M., Kimura, Y., Shimizu, N. and Arai, K. (2000). Triterpene alcohol and sterol ferulates from rice bran and their anti-inflammatory effects. J. Agr. Food Chem. 48:2313–2319.
  • Alam, M. R., Rahman, A. B., Moniruzzaman, M., Kadir, M. F., Haque, M. A., Alvi, M. R.-U.-H. and Ratan, M. (2012). Evaluation of antidiabetic phytochemicals in Syzygium cumini (L.) Skeels (Family: Myrtaceae). J. Appl. Pharmaceut. Sci. 2:94.
  • American Diabetes Association. (1987). Nutritional recommendations and principles for individuals with diabetes mellitus: 1986: American Diabetes Association. Diabetes Care. 10:126–132.
  • American Diabetes Association. (1998). Nutritional recommendations and principles for people with diabetes mellitus. Diabetes Care. 21:32–35.
  • Aronson, A. J., Glaspy, J. A., Reddy, S. T., Reese, D., Heber, D. and Bagga, D. (2001). Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology. 58:283–288.
  • Awad, A. B., Chan, K. C., Downie, A. C. and Fink, C. S. (2000). Peanuts as a source of b-sitosterol, a sterol with anticancer properties. Nutr. Cancer. 36:238–241.
  • Awad, A. B., von Holtz, R. L., Cone, J. P., Fink, C. S. and Chen, Y. C. (1998). Beta-Sitosterol inhibits growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle. Anticancer Res. 18:471–473.
  • Azadmard-Damirchi, S. (2010). Review of the use of phytosterols as a detection tool for adulteration of olive oil with hazelnut oil. Food Addit. Contaminants Part A-Chem. Anal. Contr. Expo. Risk Assess. 27:1–10.
  • Ballou, L. R. and Cheung, W. Y. (1985). Inhibition of human platelet phospholipase A2 activity by unsaturated fatty acids. Proceedings of the National Academy of Sciences of the United States of America 82:371–375.
  • Basch, E., Gabardi, S. and Ulbricht, C. (2003). Bitter melon (Momordica charantia): A review of efficacy and safety. Am. J. Health-Syst. Pharm. 60:356–359.
  • Bassuk, S. S., Albert, C. M., Cook, N. R., Zaharris, E., MacFadyen, J. G., Danielson, E., Van Denburgh, M., Buring, J. E. and Manson, J. E. (2004). The women's antioxidant cardiovascular study: Design and baseline characteristics of participants. J. Womens Health. 13:99–117.
  • Benalla, W., Bellahcen, S. and Bnouham, M. (2010). Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Current Diabetes Rev. 6:247–254.
  • Berge, R. K., Madsen, L. and Vaagenes, H. (1999). Hypolipidemic 3-thia fatty acids—Fatty acid oxidation and ketogenesis in rat liver under proliferation of mitochondria and peroxisomes. Adv. Exp. Med. Biol. 466:125–132.
  • Brigelius-Flohe, R., Kelly, F. J., Salonen, J. T., Neuzil, J., Zingg, J. M. and Azzi, A. (2002). The European perspective on vitamin E: Current knowledge and future research. Am. J. Clin. Nutr. 76:703–716.
  • Brindis, F., Rodriíguez, R., Bye, R., Gonzaílez-Andrade, M. and Mata, R. (2010). (Z)-3-Butylidenephthalide from Ligusticum porteri, an α-glucosidase inhibitor. J. Nat. Prod. 74:314–320.
  • Brunner, J., Parhofer, K. G., Schwandt, P. and Bronisch, T. (2002). Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry. 35:1–5.
  • Chang, M. K., Conkerton, E. J., Chapital, D. C., Wan, P. J., Vadhwa, O. P. and Spiers, J. M. (1996). Chinese melon ( Momordica charantia L.) seed: Composition and potential use. Journal of Oil & Fat Industries 73:263–265.
  • Chen, L. and Kang, Y. H. (2013). In vitro inhibitory effect of oriental melon (Cucumis melo L. var. makuwa Makino) seed on key enzyme linked to type 2 diabetes. J. Funct. Foods. 5:981–986.
  • Chen, L. and Kang, Y. H. (2014). Antioxidant and Enzyme Inhibitory Activities of Plebeian Herba (Salvia plebeia R. Br.) under Different Cultivation Conditions. J. Agric. Food Chem. 62: 2190–2197.
  • Chen, L., Kang, Y. H. and Suh, J. K. (2014). Roasting processed oriental melon (Cucumis melo L. var. makuwa Makino) seed influenced the triglyceride profile and the inhibitory potential against key enzymes relevant for hyperglycemia. Food Res. Int. 56:236–242.
  • Chen, S., Ostrowski, J., Whiting, G., Roalsvig, T., Hammer, L., Currier, S. J., Honeyman, J., Kwasniewski, B., Yu, K. L. and Sterzycki, R. (1995). Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J. Invest. Dermatol. 104:779–783.
  • Conforti, F., Statti, G., Loizzo, M. R., Sacchetti, G., Poli, F. and Menichini, F. (2005). In Vitro antioxidant effect and inhibition of alpha-amylase of two varieties of Amaranthus caudatus seeds. Biol. Pharm. Bull. 28:1098–1102.
  • Conquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J. and Fisher, R. H. (2000). Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids. 35:1305–1312.
  • Dans, A. M., Villarruz, M. V., Jimeno, C. A., Javelosa, M. A., Chua, J., Bautista, R. and Velez, G. G. (2007). The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J. Clin. Epidemiol. 60:554–559.
  • Darko, D., Dornhorst, A., Kelly, F. J., Ritter, J. M. and Chowienczyk, P. J. (2002). Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin. Sci. (Lond). 103:339–344.
  • Das, U. N. (2006). Essential fatty acids: Biochemistry, physiology and pathology. Biotechnol. J. 1:420–439.
  • Das, U. N., Mohan, I. K. and Raju, T. R. (2001). Effect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders. Prostaglandins Leukot. Essent. Fatty Acids. 65:197–203.
  • De Caterina, R., Madonna, R., Bertolotto, A. and Schmidt, E. B. (2007). n-3 Fatty acids in the treatment of diabetic patients: Biological rationale and clinical data. Diabetes Care. 30:1012–1026.
  • Dobrucki, L. W., Kalinowski, L., Dobrucki, I. T. and Malinski, T. (2001). Statin-stimulated nitric oxide release from endothelium. Med. Sci. Monit. 7:622–627.
  • Duester, G. (1996). Involvement of alcohol dehydrogenase, short-chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid synthesis. Biochemistry 35:12221–12227.
  • Fairfield, K. M. and Fletcher, R. H. (2002). Vitamins for chronic disease prevention in adults—scientific review. JAMA. 287:3116–3126.
  • Fatmawati, S., Shimizu, K. and Kondo, R. (2011). Ganoderol B: A potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Phytomedicine International J. Phytother. Phytopharm. 18:1053–1055.
  • Fenner, G. P., Patterson, G. W. and Lusby, W. R. (1989). Developmental regulation of sterol biosynthesis in Cucurbita maxima L. Lipids. 24:271–277.
  • Field, C. J., Ryan, E. A., Thomson, A. B. and Clandinin, M. T. (1990). Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J. Biol. Chem. 265:11143–11150.
  • Finnegan, Y. E., Minihane, A. M., Leigh-Firbank, E. C., Kew, K., Meijer, G. W., Muggli, R., Calder, P. C. and Williams, C. M. (2003). Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 77:783–795.
  • Ford, E. S., Will, J. C., Bowman, B. A. and Narayan, K. M. V. (1999). Diabetes mellitus and serum carotenoids: Findings from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 149:168–176.
  • Franz, M. J., Horton, E. S., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Coulston, A. M., Henry, R. R., Hoogwerf, B. J., Stacpoole, P. W. (1994). Nutrition principles for the management of diabetes and related complications. Diabetes Care. 17:490–518.
  • Gao, H., Huang, Y. N., Gao, B., Li, P., Inagaki, C. and Kawabata, J. (2008). Inhibitory effect on α-glucosidase by Adhatoda vasica Nees. Food Chem. 108:965–972.
  • Garg, A. (1998). High-monounsaturated-fat diets for patients with diabetes mellitus: A meta-analysis. Am. J. Clin. Nutr. 67:577–582.
  • Garg, A., Bonanome, A., Grundy, S. M., Zhang, Z. J. and Unger, R. H. (1988). Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. Eng. J. Med. 319:829–834.
  • Gillman, M. W., Cupples, L. A., Millen, B. E., Ellison, R. C. and Wolf, P. A. (1997). Inverse association of dietary fat with development of ischemic stroke in men. JAMA. 278:2145–2150.
  • Grover, J. K. and Yadav, S. P. (2004). Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol. 93:123–132.
  • Grundy, S. M. (1997). What is the desirable ratio of saturated, polyunsaturated, and monounsaturated fatty acids in the diet? Am. J. Clin. Nutr. 66:988–990.
  • Guardiola, F., Bou, R., Boatella, J. and Codony, R. (2004). Analysis of sterol oxidation products in foods. J. AOAC Int. 87:441–466.
  • Gupta, R., Sharma, A. K., Dobhal, M. P., Sharma, M. C. and Gupta, R. S. (2011). Antidiabetic and antioxidant potential of beta-sitosterol in streptozotocin-induced experimental hyperglycemia. Diabetes. 3:29–37.
  • Hetherington, M. and Steck, W. (1999). Phytosterols from Canadian plants: Uses and sources. Can. Chem. News. 51:20–21.
  • Hontecillas, R., Diguardo, M., Duran, E., Orpi, M. and Bassaganya-Riera, J. (2008). Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue. Clin. Nutr. 27:764–772.
  • Hu, F. B. and Willett, W. C. (2002). Optimal diets for prevention of coronary heart disease. JAMA. 288:2569–2578.
  • Hur, S. J., Lim, B. O., Decker, E. A. and McClements, D. J. (2011). In vitro human digestion models for food applications. Food Chem. 125:1–12.
  • Iso, H., Sato, S., Umemura, U., Kudo, M., Koike, K., Kitamura, A., Imano, H., Okamura, T., Naito, Y. and Shimamoto, T. (2002). Linoleic acid, other fatty acids, and the risk of stroke. Stroke. 33:2086–2093.
  • Ivorra, M. D., D'Ocon, M. P., Paya, M. and Villar, A. (1988). Antihyperglycemic and insulin-releasing effects of beta-sitosterol 3-beta-D-glucoside and its aglycone, beta-sitosterol. Archives Internationales De Pharmacodynamie Et De Thérapie 296:224–231.
  • Javadi, N., Abas, F., Abd Hamid, A., Simoh, S., Shaari, K., Ismail, I. S., Mediani, A. and Khatib, A. (2014). GC-MS-based metabolite profiling of Cosmos caudatus leaves possessing alpha-glucosidase inhibitory activity. J. Food Sci. 79:1130–1136.
  • Jones, P. J., Ntanios, F. Y., Raeini-Sarjaz, M. and Vanstone, C. A. (1999). Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am. J. Clin. Nutr. 69:1144–1150.
  • Jones, P. J., Raeini-Sarjaz, M., Ntanios, F. Y., Vanstone, C. A., Feng, J. Y. and Parsons, W. E. (2000). Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J. Lipid Res. 41:697–705.
  • Jones, P. J. H., MacDougall, D. E., Ntanios, F. and Vanstone, C. A. (1997). Dietary phytosterols as cholesterol-lowering agents in humans. Can. J. Physiol. Pharm. 75:217–227.
  • Julius, U. (2003). Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp. Clin. Endocrinol. Diabetes. 111:246–250.
  • Jump, D. B. and Clarke, S. D. (1999). Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 19:63–90.
  • Kim, K. Y., Nam, K. A., Kurihara, H. and Kim, S. M. (2008). Potent α-glucosidase inhibitors purified from the red alga Grateloupia elliptica. Phytochemistry 69:2820–2825.
  • Koshland, D. E. (1953). Stereochemistry and the mechanism of enzymatic reactions. Biol. Rev. 28(4):416–436.
  • Kusunoki, M., Tsutsumi, K., Nakayama, M., Kurokawa, T., Nakamura, T., Ogawa, H., Fukuzawa, Y., Morishita, M., Koide, T. and Miyata, T. (2007). Relationship between serum concentrations of saturated fatty acids and unsaturated fatty acids and the homeostasis model insulin resistance index in Japanese patients with type 2 diabetes mellitus. J. Med. Invest. 54:243–247.
  • Lee, H. S. (2005). Cuminaldehyde: Aldose reductase and alpha-glucosidase inhibitor derived from Cuminum cyminum L. seeds. J. Agr. Food Chem. 53:2446–2450.
  • Li, N., Cui, M., Lu, X. M., Qin, F., Jiang, K. and Li, F. (2010). A rapid and reliable UPLC-MS/MS method for the identification and quantification of fourteen synthetic anti-diabetic drugs in adulterated Chinese proprietary medicines and dietary supplements. Biomed. Chromatogr. 24:1255–1261.
  • Li, Y., Wen, S., Kota, B. P., Peng, G., Li, G. Q., Yamahara, J. and Roufogalis, B. D. (2005). Punica granatum flower extract, a potent α-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J. Ethnopharm. 99:239–244.
  • Ling, W. H. and Jones, P. J. (1995). Dietary phytosterols: A review of metabolism, benefits and side effects. Life Sci. 57:195–206.
  • Liu, S. M., Lee, I. M., Song, Y. Q., Van Denburgh, M., Cook, N. R., Manson, J. E. and Buring, J. E. (2006). Vitamin E and risk of type 2 diabetes in the Women's Health Study randomized controlled trial. Diabetes. 55:2856–2862.
  • Matsui, T., Tanaka, T., Tamura, S., Toshima, A., Tamaya, K., Miyata, Y., Tanaka, K. and Matsumoto, K. (2007). alpha-Glucosidase inhibitory profile of catechins and theaflavins. J. Agric. Food Chem. 55:99–105.
  • McCarter, J. D. and Withers, G. S. (1994). Mechanisms of enzymatic glycoside hydrolysis. Curr. Opin. Struc. Biol. 4:885–892.
  • Means, A. L. and Gudas, L. J. (1995). The Roles of Retinoids in Vertebrate Devel. Annual Rev. Biochem. 64:201–233.
  • Mehmood, S., Orhan, K., Ahsan, Z., Aslan, S. and Gulfraz, M. (2008). Fatty acid composition of seed oil of different Sorghum bicolor varieties. Food Chem. 109:855–859.
  • Miyazawa, M., Yagi, N. and Taguchi, K. (2005). Inhibitory compounds of .alpha.-glucosidase activity from Arctium lappa L. J. Oil. Chemist's Soc. Japan. 54:589–594.
  • Montonen, J., Knekt, P., Jarvinen, R. and Reunanen, A. (2004). Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care. 27:362–366.
  • Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., Watts, G. F. and Beilin, L. J. (1999). Dietary fish as a major component of a weight-loss diet: Effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am. J. Clin. Nutr. 70:817–825.
  • Murkovic, M., Hillebrand, A., Winkler, J. and Pfannhauser, W. (1996). Variability of vitamin E content in pumpkin seeds (Cucurbita pepo L). Z. Lebensm. Unters. Forsch. 202:275–278.
  • Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R. and Zinman, B. (2009). Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 32:193–203.
  • Nguyen, T. H., Um, B. H. and Kim, S. M. (2011). Two unsaturated fatty acids with potent alpha-glucosidase inhibitory activity purified from the body wall of sea cucumber (Stichopus japonicus). J. Food Sci. 76:208–214.
  • Okuda, Y., Kawashima, K., Sawada, T., Tsurumaru, K., Asano, M., Suzuki, S., Soma, M., Nakajima, T. and Yamashita, K. (1997). Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem. Biophys. Res. Commun. 232:487–491.
  • Omobuwajo, T. O., Sanni, L. A. and Balami, Y. A. (2000). Physical properties of sorrel (Hibiscus sabdariffa) seeds. J. Food Eng. 45:37–41.
  • Palace, V. P. and Brown, S. B. (1994). HPLC determinatielinus namaycush) exposed to coplanar 3,3′,4,4′,5-pentachlorobiphenyl. Environment. Toxicol. Chem. 13:473–476.
  • Pan, H. J., Lin, Y. M., Chen, Y. Q. E., Vance, D. E. and Leiter, E. H. (2006). Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: Relation to dysregulated phosphatidylcholine metabolism. Vascul. Pharmacol. 45:65–71.
  • Pande, S. V. and Mead, J. F. (1968). Inhibition of enzyme activities by free fatty acids. J. Biol. Chem. 243:6180–6185.
  • Paolisso, G., Balbi, V., Volpe, C., Varricchio, G., Gambardella, A., Saccomanno, F., Ammendola, S., Varricchio, M. and Donofrio, F. (1995). Metabolic benefits deriving from chronic vitamin-C supplementation in aged non-insulin-dependent diabetics. J. Am. Coll. Nutr. 14:387–392.
  • Park, H., Hwang, K. Y., Kim, Y. H., Oh, K. H., Lee, J. Y. and Kim, K. (2008). Discovery and biological evaluation of novel α-glucosidase inhibitors with in vivo antidiabetic effect. Bioorg. Med. Chem. Lett. 18(13):3711–3715.
  • Paul, S., Hou, C. T. and Kang, S. C. (2010). alpha-Glucosidase inhibitory activities of 10-hydroxy-8(E)-octadecenoic acid: An intermediate of bioconversion of oleic acid to 7,10-dihydroxy-8(E)-octadecenoic acid. N. Biotechnol. 27:419–423.
  • Pegel, K. H. (1997). The importance of sitosterol and sitosterolin in human and animal nutrition. South African J. Sci. 93:263–268.
  • Phillips, K. M., Ruggio, D. M. and Ashraf-Khorassani, M. (2005). Phytosterol composition of nuts and seeds commonly consumed in the United States. J. Agr. Food Chem. 53:9436–9445.
  • Phillips, K. M., Ruggio, D. M., Toivo, J. I., Swank, M. A. and Simpkins, A. H. (2002). Free and esterified sterol composition of edible oils and fats. J. Food Composit. Anal. 15:123–142.
  • Qian, M., Haser, R., Buisson, G., Duee, E. and Payan, F. (1994). The active center of a mammalian alpha-amylase. Structure of the complex of a pancreatic alpha-amylase with a carbohydrate inhibitor refined to 2.2-A resolution. Biochemistry. 33:6284–6294.
  • Qian, M., Nahoum, V., Bonicel, J., Bischoff, H., Henrissat, B. and Payan, F. (2001). Enzyme-catalyzed condensation reaction in a mammalian α-amylase. High-resolution structural analysis of an enzyme-inhibitor complex. Biochemistry. 40:7700–7709.
  • Reddy, P. P., Tiwari, A. K., Rao, R. R., Madhusudhana, K., Rao, V. R. S., Ali, A. Z., Babu, K. S. and Rao, J. M. (2009). New Labdane diterpenes as intestinal alpha-glucosidase inhibitor from antihyperglycemic extract of Hedychium spicatum (Ham. Ex Smith) rhizomes. Bioorg. Med. Chem. Lett. 19:2562–2565.
  • Regensteiner, J. G., Popylisen, S., Bauer, T. A., Lindenfeld, J., Gill, E., Smith, S., Oliver-Pickett, C. K., Reusch, J. E. and Weil, J. V. (2003). Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes. Vasc. Med. 8:169–175.
  • Saito, N., Sakai, H., Suzuki, S., Sekihara, H. and Yajima, Y. (1998). Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients. J. Intern. Med. Res. 26:219–232.
  • Sels, J. P., Huijberts, M. S. and Wolffenbuttel, B. H. (1999). Miglitol, a new alpha-glucosidase inhibitor. Expert Opinion Pharm. 1:149–156.
  • Sierra, S., Lara-Villoslada, F., Comalada, M., Olivares, M. and Xaus, J. (2006). Dietary fish oil n-3 fatty acids increase regulatory cytokine production and exert anti-inflammatory effects in two murine models of inflammation. Lipids. 41:1115–1125.
  • Standl, E., Baumgartl, H. J., Füchtenbusch, M. and Stemplinger, J. (1999). Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes. Metab. 1:215–220.
  • Subash-Babu, P. and Ignacimuthu, S. (2007). Antihyperlipidemic and Antioxidant Effect of Hyponidd in the Brain of Streptozotocin Induced Diabetic Rat. Intern. J. Biolog. Chem. 1:196–204.
  • Su, C. H., Hsu, C. H. and Ng, L. T. (2013). Inhibitory potential of fatty acids on key enzymes related to type 2 diabetes. Biofactors. 39:415–421.
  • Suzuki, K., Shono, F., Kai, H., Uno, T. and Uyeda, M. (2000). Inhibition of topoisomerases by fatty acids. J. Enzym. Inhib. 15:357–366.
  • Tabussum, A., Riaz, N., Saleem, M., Ashraf, M., Ahmad, M., Alam, U., Jabeen, B., Malik, A. and Jabbar, A. (2013). alpha-Glucosidase inhibitory constituents from Chrozophora plicata. Phytochem. Lett. 6:614–619.
  • Trautwein, E. A. and Duchateau, G. S. M. J. E. (2006). Phytosterol: Sources and metabolism. In: Nutrtion and Cancer Prevention, pp. 223–241, Awad, A. B. and Bradford, P. G., Ed., CRC Press, New York.
  • Tundis, R., Loizzo, M. R., Menichini, F., Bonesi, M., Conforti, F., Statti, G., De Luca, D., de Cindio, B. and Menichini, F. (2011). Comparative study on the chemical composition, antioxidant properties and hypoglycaemic activities of two Capsicum annuum L. cultivars (Acuminatum small and Cerasiferum). Plant Foods Hum. Nutr. 66:261–269.
  • Vetrichelvan, T. and Jegadeesan, M. (2002). Anti-diabetic activity of alcoholic extract of Aerva lanata (L.) Juss. ex Schultes in rats. J. Ethnopharm. 80:103–107.
  • Wallace, A. C., Laskowski, R. A. and Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein–ligand interactions. Protein. Eng. 8:127–134.
  • Watanabe, J., Kawabata, J., Kurihara, H. and Niki, R. (1997). Isolation and identification of alpha-glucosidase inhibitors from tochu-cha (Eucommia ulmoides). Biosci. Biotech. Biochem. 61:177–178.
  • Yamamoto, K., Miyake, H., Kusunoki, M. and Osaki, S. (2010). Crystal structures of isomaltase from Saccharomyces cerevisiae and in complex with its competitive inhibitor maltose. FEBS J. 277:4205–4214.
  • Yoshikawa, M., Murakami, T., Harada, E., Murakami, N., Yamahara, J. and Matsuda, H. (1996). Bioactive saponins and glycosides. VII. On the hypoglycemic principles from the root cortex of Aralia elata Seem.: structure related hypoglycemic activity of oleanolic acid oligoglycoside. Chem. Pharm. Bulletin 44:1923–1927.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.